vTv Therapeutics (VTVT) Earnings Analysis

vTv Therapeutics (VTVT) has no confirmed upcoming earnings date. Last quarter (2026-03-10) it beat with EPS -0.58 USD vs -0.98 USD est (+40.8%). It has beaten estimates in 2/4 recent quarters (50%). Trailing P/E 1583.50.

Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades

When does VTVT next report earnings?

No confirmed upcoming earnings date is currently scheduled for VTVT. This page updates as the calendar is published.

VTVT earnings history — beats and misses

Quarter (report date)EPS actualEPS est.SurpriseResult
2026-03-10-0.58 USD-0.98 USD+40.8%Beat
2025-11-06-1.08 USD-0.97 USD-11.3%Miss
2025-05-15-0.77 USD-0.73 USD-5.5%Miss
2025-03-20-0.55 USD-0.87 USD+36.8%Beat

Beat rate: 2/4 (50%) over reported quarters with consensus data.

VTVT valuation and analyst view

Trailing P/E1583.50
Trailing EPS0.26734 USD
Price / book2.97
Dividend yield0.00%
Market cap0.08B
Analyst consensusBuy (7 buy / 7 hold / 0 sell)
Avg price target51.33 USD

Related research pages

Frequently asked questions

When is vTv Therapeutics (VTVT)'s next earnings date?

No confirmed upcoming earnings date is currently scheduled for VTVT. This page updates as the calendar is published.

Did VTVT beat earnings last quarter?

In its 2026-03-10 report, VTVT posted EPS of -0.58 USD versus a -0.98 USD estimate — a beat of 40.8%.

What is VTVT's earnings track record?

Over the last 4 reported quarters with consensus data, VTVT beat estimates 2 times (50%).

What is VTVT's current P/E ratio and EPS?

VTVT trades at a trailing P/E of 1583.50 on trailing EPS of 0.267343112804548 USD.

What do analysts rate VTVT?

Analyst consensus is "Buy" across 14 ratings (0 strong buy, 7 buy, 7 hold, 0 sell, 0 strong sell). Average 12-month price target: 51.33 USD.